Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab, an Investigational Treatment for IgG4-Related Disease (IgG4-RD), in The Lancet Rheumatology
Study found obexelimab produced rapid, strong, and sustained clinical improvement, including complete clinical remission, in most patients with active IgG4-RD Results support the continued development of obexelimab for the treatment
Conagen and Sumitomo Chemical jointly develop a new era of renewable carbon materials
Bedford, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Conagen, the bioplatform innovator and biomanufacturer, and Sumitomo Chemical, Japan’s leading chemical company, have announced to jointly develop p-hydroxystyrene (HS) and its
Chairman Pakistan People’s Party and Foreign Minister Bilawal Bhutto Zardari strongly condemns the terrorist attack on the anti-polio team in Quetta
Karachi, August 01, 2023 (PPI-OT): Chairman Pakistan People’s Party (PPP) and Foreign Minister Bilawal Bhutto Zardari has strongly condemned the terrorist attack on the anti-polio team in Quetta. According to
Alternative, rational thinking must for vibrant societies: Dr Jaffar
Karachi, August 01, 2023 (PPI-OT): The vibrant societies are open to alternative rational thoughts and ideas, while the closed societies live in dogma, said Prof Dr Syed Jaffar Ahmed, addressing
DRS Admission Test Fall 2023 Rescheduled
Islamabad, August 01, 2023 (PPI-OT): DRS test (DPT, BS-SLP, BS-AUD and MSPT) has been rescheduled to Thursday, 3rd August 2023.For more information, contact:Shifa Tameer-e-Millat University (STMU)Gate No.1. Shifa International Hospitals,Pitras
Ph.D. Public Defense and Viva Voce Examination of Ms. Humera Malik
Lahore, August 01, 2023 (PPI-OT): A public defence/viva voce of PhD thesis of Ms. Humera Malik has been scheduled on Monday, August 7, 2023 at 11:00 a.m. in the Committee